Protalix BioTherapeutics CEO Dror Bashan's 2022 pay jumps 27% to $1.5M
Protalix BioTherapeutics reports 2022 executive compensation
By ExecPay News
Published: May 18, 2023
Protalix BioTherapeutics reported fiscal year 2022 executive compensation information on May 18, 2023.
In 2022, three executives at Protalix BioTherapeutics received on average a compensation package of $1M, a 30% increase compared to previous year.
Average pay of disclosed executives at Protalix BioTherapeutics
Dror Bashan, Chief Executive Officer, received $1.5M in total, which increased by 27% compared to 2021. 56% of Bashan's compensation, or $818K, was in stock awards. Bashan also received $178K in option awards, $360K in salary, as well as $113K in other compensation.
Eyal Rubin, Chief Financial Officer, received a compensation package of $1.1M, which increased by 26% compared to previous year. 38% of the compensation package, or $398K, was in bonus.
Yaron Naos, Senior Vice President, Operations, earned $533K in 2022, a 6% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on May 18, 2023.